Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-MAG Polyclonal Antibody

Catalog #:   PHD43401 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P20916
Overview

Catalog No.

PHD43401

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human MAG (Ser133-Lys237).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

Myelin-associated glycoprotein,MAG,Siglec-4a,GMA

Purification

Purified by antigen affinity column.

Accession

P20916

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • WESTERN BLOT
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with MAG antibody (PHD43401) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 38 kDa
    Observed MW: 38 kDa
References

Clinical and Electrodiagnostic Findings in Anti-myelin-Associated Glycoprotein Antibody Polyneuropathy: A Single Center Review., PMID:40513035

Anti-Tumor Activities of Anti-Siglec-15 Chimeric Heavy-Chain Antibodies., PMID:40507880

Nerve ultrasound in the diagnosis of inflammatory neuropathies., PMID:40501305

[Diffuse large B-cell lymphoma presenting with anti-MAG/SGPG IgM gammopathy and neurolymphomatosis at onset]., PMID:40467458

Severe Worsening of Neuropathy Associated With Antibodies Against Myelin-Associated Glycoprotein by Rituximab Resembling Chronic Inflammatory Demyelinating Polyneuropathy., PMID:40452709

Secreted EMC10 inhibits muscle GLUT4 activity and glucose uptake in mice., PMID:40441535

Coexistence of anti-MOG and anti-MAG antibodies in combined central and peripheral nervous system demyelination: a case of dual myelinopathy., PMID:40418511

Treatment of Anti-Myelin-Associated Glycoprotein (MAG) Antibody Neuropathy Using Zanubrutinib in a Patient With Waldenström Macroglobulinemia: A Clinical Vignette., PMID:40351903

Treatment of Anti-Myelin-Associated Glycoprotein Neuropathy with Tirabrutinib and a 3-Year Follow-Up: A Case Report., PMID:40301028

[Rapidly progressive muscle weakness in anti-myelin associated glycoprotein (MAG) neuropathy successfully treated with intravenous immunoglobulin]., PMID:40139810

Methodology for the international working group clinical practice guidelines on X-linked hypophosphatemia in children and adults., PMID:40119067

Acute kidney injury, coagulopathy, and deep vein thrombosis following a haemotoxic snakebite: A case report from a resource-limited setting., PMID:40118158

Acute onset anti-MAG neuropathy and paradoxical worsening to rituximab: a challenging case., PMID:40053180

Immunogenicity, Efficacy, and Effectiveness of Two-Dose and Shorter Schedules of Hepatitis E Vaccine: A Systematic Review., PMID:39852808

The impact of blood eosinophil count and FeNO on benralizumab effectiveness in clinical practice: An ORBE II subanalysis., PMID:39814271

Lentivirus-mediated gene therapy for Fabry disease: 5-year End-of-Study results from the Canadian FACTs trial., PMID:39794302

Learning the language of antibody hypervariability., PMID:39793083

[Diseases Separated from Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Anti-Myelin-Associated Glycoprotein Neuropathy and Autoimmune Nodopathy]., PMID:39725755

Neuropathy with anti-myelin-associated glycoprotein antibodies: update on diagnosis, pathophysiology and management., PMID:39658134

Do specific myelin autoantibodies and increased cerebral dopamine neurotrophic factor in the context of inflammation predict the diagnosis of attention deficit hyperactivity disorder in medication-free children?, PMID:39617068

The Role of Complement Activation in IgM M-Protein-Associated Neuropathies., PMID:39571136

Complement activation by IgM autoantibodies linked to immune-mediated neuropathies depends on C2., PMID:39545641

IgA Vasculitis (Henoch-Schönlein Purpura): An Update on Treatment., PMID:39518760

Monoclonal Gammopathy in Patients with Neuropathy., PMID:39506578

Optimizing Anti-Myelin-Associated Glycoprotein and IgM-Gammopathy Testing for Neuropathy Treatment Evaluation., PMID:39499873

Anti-Myelin-Associated Glycoprotein Neuropathy: Recent Developments., PMID:39399552

Primary neurolymphomatosis with MAG antibody: a case report., PMID:39237863

PREVAX: A Phase I Clinical Trial of an EGF-Based Vaccine in Moderate-to-Severe COPD Patients., PMID:39203959

Polyneuropathy in systemic sclerosis: exploring the causes and biomarkers., PMID:39156689

Antibodies in Autoimmune Neuropathies: What to Test, How to Test, Why to Test., PMID:39088795

Comparison of uridine and N1-methylpseudouridine mRNA platforms in development of an Andes virus vaccine., PMID:39080316

Molecular imaging for non-invasive risk stratification of renal masses., PMID:39054210

Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma., PMID:39043638

Uncommon Presentation of IgM Monoclonal Gammopathy of Undetermined Significance (MGUS) and Anti-Myelin-Associated Glycoprotein (MAG)-Associated Demyelinating Peripheral Neuropathy as Respiratory Failure: A Case Report., PMID:38912071

Tell-tale immune-related neurological syndromes: Should we look for and underlying low-grade B-cell lymphoma? A retrospective study on 12 cases., PMID:38850875

Paraproteinemic neuropathies., PMID:38816958

Enhancing the sequence coverage of nanodiamond-extracted early secretory proteins from the Mycobacterium tuberculosis complex., PMID:38804556

[Anti-Myelin-associated Glycoprotein Neuropathy]., PMID:38741494

[Cutting edge of diagnosis and treatment for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) based on the EAN/PNS guideline 2021]., PMID:38644208

Time course of the autoantibody response to therapy in anti-MAG neuropathy: TWO case REPORTS., PMID:38601656

EMC10 modulates hepatic ER stress and steatosis in an isoform-specific manner., PMID:38599383

Inter-laboratory comparison of routine autoantibody detection methods for autoimmune neuropathies and myasthenia gravis., PMID:38578496

Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases., PMID:38529039

Paraneoplastic neuropathies and peripheral nerve hyperexcitability disorders., PMID:38494281

Consequences of COVID-19 on Adipose Tissue Signatures., PMID:38474155

Typical CIDP, distal variant CIDP, and anti-MAG antibody neuropathy: An ultra-high frequency ultrasound comparison of nerve structure., PMID:38409319

Prevalence and clinical profiles of anti-myelin-associated glycoprotein neuropathy in Japan: A nationwide survey study of 133 patients., PMID:38375741

Anti-MAG neuropathy: historical aspects, clinical-pathological correlations, and considerations for future therapeutical trials., PMID:38325389

Mode of progression in smoldering multiple myeloma: a study of 406 patients., PMID:38228628

Upper and lower limb tremor in inflammatory neuropathies., PMID:38194761

Datasheet

Document Download

Anti-MAG Polyclonal Antibody.pdf

 

$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-MAG Polyclonal Antibody [PHD43401]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only